Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
Background. Paraoxonase-1 (PON1) is the crucial antioxidant marker of high-density lipoproteins. The present study is aimed at assessing the effect of simvastatin treatment on PON1 activity and its relationship to Q192R and M55L polymorphisms in subjects with stable coronary artery disease (CAD). Me...
Saved in:
| Main Author: | Rafał Januszek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Vascular Medicine |
| Online Access: | http://dx.doi.org/10.1155/2016/6312478 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunological changes in patients with community-acquired pneumonia with concomitant coronary artery disease during treatment with Simvastatin
by: V. V. Syvolap, et al.
Published: (2016-03-01) -
Antioxidant effects of simvastatin in patients with coronary heart disease and dyslipidemia
by: N. E. Artamoshina, et al.
Published: (2012-12-01) -
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
by: Rakesh S Birjmohun, et al.
Published: (2009-08-01) -
The importance of paraoxonase 1 activity in chronic kidney disease
by: Elisabeth C. Samouilidou, et al.
Published: (2024-12-01) -
Stabilizing Stable Coronary Artery Disease
by: Kuan-Yu Chi, MD, et al.
Published: (2025-02-01)